King & Wood Mallesons has hired a former Paul Hastings partner as counsel in Hong Kong.

Jason Kuo specializes in capital markets deals. He advises on the U.S. law aspects of Hong Kong listings and relevant transactions. Last year, he represented Hong Kong-based biopharmaceutical company SinoMab BioScience Ltd. on a $177 million initial public offering.

Kuo joined Paul Hastings in 2018 from Troutman Sanders where he was a Hong Kong partner. Before moving to Troutman in 2016, he spent 18 years with Sidley Austin, and had been a partner there since 2008.